Sign in

NCT07380295Recruiting

Improving Workforce Participation and Well-Being in Individuals With Multiple Sclerosis - A Feasability Study

Improving Workforce Participation and Well-Being in Individuals With Multiple Sclerosis- A Feasability Study

Source: ClinicalTrials.gov · Last updated 2 Feb 2026

Brief summary (registry, in English)

Multiple sclerosis (MS) is a chronic neurodegenerative disease and a leading cause of reduced workforce participation due to neurological illness in Western countries. Over the past 30 years, new treatments have reduced symptom burden, allowing patients to stay in the workforce longer. However, fatigue and cognitive impairments remain major barriers to work capacity. This project aims to preliminary examine the impact of cognitive function on work ability, and assess the role of neuropsychologists in multidisciplinary rehabilitation teams. It consists of a feasibility study evaluating the integration of neuropsychological interventions into teambased work-oriented rehabilitation. The specific research questions are: 1. How can neuropsychological interventions be integrated into team-based work-oriented rehabilitation? 2. How do these interventions relate to work ability and well-being in individuals with MS? The investigators plan to collect data on 20 consecutively patients with MS before, 6 months after and 2 years after a neuropsychological testing and intervention. The patients are being followed on measures related to well-being and work ability. Data from the neuropsychological assessment, other rehabilitation interventions as well as data related to treatment and progress of MS are also collected. Our findings aim to enhance work-oriented rehabilitation and provide a deeper understanding of how to support individuals with MS in maintaining employment and overall well-being

Status (registry)
Recruiting
Study type
Observational
Enrollment
20 (estimated)
First submitted
22 Sept 2025
Start date
22 Jul 2025
Primary completion date
Sept 2028
Lead sponsor
Region Gävleborg
NCT number
NCT07380295

What you commit to

  • Study type: Observational
  • Planned participants: 20
  • From 22 Jul 2025 to the primary completion date, Sept 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Other diagnosis hindering work participation more than MS
  • \-

Who the study is looking for

  • Multiple sclerosis Age between 18-65 Refered to neuropsychological assessment at the Neurology departement at Gävle Hospital -

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Gävle Hospital
Coordinator of this site? Confirm its status
GävleSwedenRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.